| abstract |
The first invention includes dialkyl fumarate, monoalkyl fumarate, fumaric acid monoalkyl ester salt, fumaric acid monoamide, monoamide fumarate, fumaric acid diamide, monoalkyl monoamide fumarate, carbocycle and oxacarbocycle of these compounds It relates to a medicament for the treatment or prevention of heart failure, in particular left ventricular failure, myocardial infarction and angina pectoris, comprising a fumaric acid derivative selected from the group consisting of oligomers and mixtures of said compounds. The second invention relates to dialkyl fumarate, monoalkyl fumarate, fumaric acid monoalkyl ester salt, fumaric acid monoamide, monoamide fumarate, fumaric acid diamide, monoalkyl monoamide fumarate, carbocycle and oxacarbocycle of these compounds Asthma, chronic obstructive pulmonary disease, especially asthma caused by allergies, infections, analgesics, work conditions or physical effort, containing a oligomer, and a fumaric acid derivative selected from the group consisting of mixtures of the aforementioned compounds The present invention relates to a therapeutic agent for type asthma or cardiac asthma. |